Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.76 |
| ▸ | MAPT | P10636 | 6/20 | 0.76 |
| ▸ | HTT | P42858 | 6/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.76 |
| ▸ | NPC1 | O15118 | 5/20 | 0.76 |
| ▸ | CDC25A | P30304 | 3/20 | 0.76 |
| ▸ | CDC25B | P30305 | 3/20 | 0.76 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.76 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.76 |
| ▸ | HK1 | P19367 | 1/20 | 0.76 |
| ▸ | CDC25C | P30307 | 1/20 | 0.76 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | ATM | Q13315 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251773 | 0.79 | TSHR (0.67) | RAB9AKMT2AMAPTHTTNPSR1 | |
| SCHEMBL11177087 | 0.78 | TSHR (0.74) | RAB9AKMT2AMAPTHTTNPSR1 | |
| SCHEMBL13868991 | 0.77 | KMT2A (0.76) | RAB9AKMT2AMAPTHTTNPSR1 | |
| SCHEMBL13417403 | 0.74 | MAPT (0.50) | RAB9AKMT2AMAPTHTTNPSR1 | |
| SCHEMBL9479471 | 0.73 | MAPK13 (0.72) | KMT2AMAPTMAPK1L3MBTL1MEN1 | |
| 4-Phenylamino Benzoic Acid SCHEMBL70190 | 0.73 | MAPK13 (0.72) | KMT2AMAPTMAPK1L3MBTL1MEN1 | |
| SCHEMBL16583990 | 0.72 | TSHR (0.62) | RAB9AKMT2AMAPTHTTNPSR1 | |
| SCHEMBL31612179 | 0.72 | PTPN6 (1.00) | RAB9AKMT2AMAPTHTTNPSR1 | |
| SCHEMBL2127845 | 0.71 | TYR (0.73) | RAB9AMAPTHTTNPC1ATM | |
| Terephthalic Acid SCHEMBL31588347 | 0.71 | TSHR (0.92) | ALDH1A1SMN1; SMN2TSHRALOX15TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524953-B2 | Triphendioxazine pigments | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-04-28 | — | — | US | disclosed |
| US-7524953-B2 | Triphendioxazine pigments | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-04-28 | — | — | US | disclosed |
| EP-1706459-B1 | TRIPHENDIOXAZINE PIGMENTS | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2008-11-19 | — | — | EP | disclosed |
| US-20080234480-A1 | Triphendioxazine Pigments | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-09-25 | — | — | US | disclosed |
| US-20080234480-A1 | Triphendioxazine Pigments | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234480-A1 | Triphendioxazine Pigments | NR2E3, NR2C2, NR4A1 | RAB9A 4215/4885KMT2A 365/4885MAPT 3568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.